Search

everythinglearnresearchcommunity

for

Search:↓

Certain miRNAs might be involved in a hair loss condition called frontal fibrosing alopecia and could possibly help in its diagnosis.

Disodium folinate can safely and effectively replace calcium folinate in colorectal cancer treatment.

Systemic treatments like hydroxychloroquine and cyclosporine A help with Lichen Planopilaris and Frontal Fibrosing Alopecia, but ongoing treatment is needed.

Frontal fibrosing alopecia may affect nails and could be a type of lichen planus, treatable with certain medications.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Finasteride helps treat hair loss by blocking enzyme activity.

DA-9401 can protect against finasteride-induced reproductive damage in rats.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Oral JAK inhibitors show promise for treating alopecia areata but have challenges like relapse and side effects.

In 2024, the FDA approved 50 new drugs, including treatments for hair loss, anemia, high blood pressure, and Alzheimer's.

HST and HST/F promote hair growth and may help treat alopecia.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Lymecycline may help with Frontal Fibrosing Alopecia but needs more research.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Sunscreen particles were not found in inflamed or fibrotic areas of skin in FFA patients, suggesting no direct link to the disease.

Certain medications can cause gum problems, so patients and healthcare providers should be aware and monitor oral health.

A woman with an unusual pattern of hair loss was confirmed to have Frontal Fibrosing Alopecia and treated with specific medications.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Papain from papaya may help treat cardiovascular diseases by breaking down fibrin.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Frontal fibrosing alopecia can be diagnosed by examining facial areas and treated with specific medications to stop its progression.

New compounds show promise as nonsteroidal treatments for hair loss.